Cambridge Investment Research Advisors
GDRX icon

Cambridge Investment Research Advisors’s GoodRx Holdings GDRX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,837
Closed -$239K – 3211
2021
Q3 		$239K Sell
5,837
-3,620
-38% -$131K ﹤0.01% 2649
2021
Q2 		$341K Sell
9,457
-19,110
-67% -$705K ﹤0.01% 2376
2021
Q1 		$1.11M Buy
+28,567
New +$1.28M 0.01% 1362

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Cambridge Investment Research Advisors's GDRX Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 5,837 shares — an estimated $239K sold.

Cambridge Investment Research Advisors first reported a position in GDRX in Q1 2021 and held it in 3 quarters. The position peaked at $1.11M in Q1 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,837 GoodRx Holdings shares in Q4 2021, an estimated $239K.
  • Cambridge Investment Research Advisors first reported a position in GoodRx Holdings in Q1 2021 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's GoodRx Holdings position peaked at $1.11M in Q1 2021.
  • 216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.